Dr. Siddhartha Dutta

drugs recent advances pharmacotheapy pharmaceutical pharmacodynamics immunology current therapy pharmacokinetics drug development clinical trial clinical research alzheimer disease diagnostic drugs drug delivery systems anticancer cancer vaccines medicine pharmacogenomics healthcare receptor pharmacology mechanism biased agonism treatment phases of clinical trial research drugs and cosmetics schedule y pharmacotherapy future prospects physiology neurotransmitters snake bite myasthenia gravis onganophosphorus poisioning poisioning glaucoma acetylcholine esterases anticholinergics cholinomimetics introduction cholineesterases atropine acetyl choline autonomic drugs cholinergic system autonomic nervous system chemotherapy receptor agonist pharma interferons zinc enzymes secretase dopamine neurology neurodegeneration neurodegenerative disorders amyotrophic lateral sclerosis wilsons disease huntingtons disease multiple sclerosis parkinsonism parkinson disease phentolamine test dexamethasone test steroid narcoanalysis diagnostic agents scanning radiation radiology dyes diagnosis infrared radiowaves radio gold nanoparticles nanomedicine nanotechnology malignancy liposomes new immunocontraception injectable spray transdermal ocp male female hormonal contraceptives contraception side effects adverse drug reaction factors affecting drug metabolism excretion metabolism compliance children pediatrics old age elderly physiological conditions prescribing health cytochrome p450 amplichip dna p drug personalized medicine g6pd genetic polymorphisms polymorphisms mutation gene gene therapy lead generation drug pricing pricing authority health economiics medical care perspectives types of cost costs pharmaceutical industry economics pharmacoeconomic study design direct cost ispor pharmacoeconomics randomized control trial first in human microdosing study phase 0 phase 5 drug discovery pharmacolology immunological assay chemical assay culture microbiological assay principle photometry radioimmunoassay elisa gas chromatography chromatography tlc organ bath prerequisites types of assays colorimetry hplc bioassay assay angiostensin receptors pros and cons h2 receptor blocker morphine gpcr agonist platelet activating factor beta blockers recent famotidine hca2 new concepts beta arrestin receptors internalisation desensitization delta receptors therapy inverse agonist partial agonist antagonist theories of receptor pharmacology receptor spare receptors types insulin pump diabetes insulin diabetes mellitus oral hypoglycaemic agents dcgi cdsco law new chemical entity regulations regulatory industry coxibs prostaglandins psoriasis non pharmacological management management siezures epilepsy scope phases of reverse pharmacology reverse pharmacology india pharmacological modulation cox nsaids